
Beneficient (NASDAQ:BENF – Free Report) – Equities researchers at Sidoti Csr reduced their Q4 2027 EPS estimates for Beneficient in a research note issued on Tuesday, November 4th. Sidoti Csr analyst B. Mccarthy now anticipates that the company will earn $0.04 per share for the quarter, down from their previous forecast of $0.08. The consensus estimate for Beneficient’s current full-year earnings is ($2.29) per share.
A number of other analysts also recently commented on BENF. Wall Street Zen raised Beneficient to a “sell” rating in a research report on Saturday. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Beneficient in a research report on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.
Beneficient Trading Down 4.4%
NASDAQ:BENF opened at $0.69 on Wednesday. The firm has a 50-day moving average price of $0.57 and a two-hundred day moving average price of $0.40. Beneficient has a 52 week low of $0.22 and a 52 week high of $2.36.
Beneficient (NASDAQ:BENF – Get Free Report) last posted its quarterly earnings data on Tuesday, October 21st. The company reported ($0.85) EPS for the quarter. The business had revenue of ($12.62) million for the quarter.
About Beneficient
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Recommended Stories
- Five stocks we like better than Beneficient
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Reasons Tesla Could Be a $500 Stock by the End of the Month
- Most active stocks: Dollar volume vs share volume
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
- Asset Allocation Strategies in Volatile Markets
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
